← Back to Search

Mindfulness Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

Waitlist Available
Led By Stephen P Becker, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meet full DSM-5 criteria for ADHD (per protocol).
Meet full DSM-5 criteria for ADHD (per protocol)
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will look at whether mindfulness meditation (MAPs) can help treat ADHD & co-occurring cognitive disengagement syndrome (CDS) in adolescents. Results will provide key data on treating CDS in those with ADHD.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
You have been diagnosed with ADHD and meet the full criteria for it.
You have been diagnosed with ADHD according to the DSM-5 guidelines.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Secondary outcome measures
Attention Deficit Disorder
Change in mind wandering: Mind-Wandering Questionnaire (MWQ)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mindfulness TreatmentExperimental Treatment1 Intervention
This arm consists of the mindfulness treatment that will be administered to all participants in the single-arm open trial.
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Awareness Practices (MAPs)

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
806 Previous Clinical Trials
5,530,919 Total Patients Enrolled
31 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
3,981 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Stephen P Becker, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigative endeavor open to applicants who are over 40 years of age?

"The requirements for this research study mandates that participants be between 13 and 17 years old. Out of the 126 total trials, 98 are specifically tailored to minors while 28 apply to elderly individuals."

Answered by AI

Are there opportunities for volunteers to enroll in this trial at present?

"Indeed, clinicaltrials.gov verifies that this trial is still recruiting participants. It was posted on October 5th 2022 and has seen an update as recently as the 14th of October 2022. Currently it requires 15 patients to be enrolled at one medical site."

Answered by AI

What is the scope of participants enrolled in this clinical trial?

"Affirmative. According to clinicaltrials.gov, this medical examination is actively seeking volunteers and was initially posted on October 5th 2022 before receiving its most recent update on the 14th of that same month. Currently, they are looking for 15 participants from a single medical site."

Answered by AI
~7 spots leftby Feb 2025